We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.66%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.03B
AUM Growth
+$1.87B
(+26%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
18.63%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,787
New
329
Increased
1,367
Reduced
42
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$58.9M |
| 2 |
Microsoft
MSFT
|
+$45.4M |
| 3 |
Amazon
AMZN
|
+$30.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$28.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$2M |
| 2 |
ProShares Merger ETF
MRGR
|
+$1.93M |
| 3 |
Alcoa
AA
|
+$1.78M |
| 4 |
RALS
ProShares RAFI Long/Short
RALS
|
+$1.32M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.42% |
| 2 | Healthcare | 14.55% |
| 3 | Technology | 12.09% |
| 4 | Consumer Staples | 11.44% |
| 5 | Industrials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Avanos Medical
AVNS
$1.17B
| $476K | 0.01% |
12,879
+3,735
| +41% | +$133K |
|
|
PRA
1102
DELISTED
ProAssurance
PRA
| $475K | 0.01% |
8,447
+231
| +3% | +$12.8K |
|
|
VSM
1103
DELISTED
Versum Materials, Inc.
VSM
| $475K | 0.01% |
+16,938
| New | +$422K |
|
|
NSR
1104
DELISTED
Neustar Inc
NSR
| $475K | 0.01% |
14,221
+4,401
| +45% | +$117K |
|
1105
Integra LifeSciences
IART
$1.54B
| $474K | 0.01% |
11,042
+3,888
| +54% | +$158K |
|
|
WBMD
1106
DELISTED
WebMD Health Corp.
WBMD
| $473K | 0.01% |
9,550
+2,836
| +42% | +$147K |
|
1107
Deckers Outdoor
DECK
$13.3B
| $471K | 0.01% |
50,988
+15,606
| +44% | +$150K |
|
1108
Toll Brothers
TOL
$14B
| $471K | 0.01% |
15,202
+2,601
| +21% | +$77.1K |
|
|
INSY
1109
DELISTED
Insys Therapeutics, Inc.
INSY
| $471K | 0.01% |
51,188
+3,713
| +8% | +$41.9K |
|
1110
LCI Industries
LCII
$2.51B
| $470K | 0.01% |
4,361
+1,529
| +54% | +$152K |
|
1111
Tetra Tech
TTEK
$8.23B
| $468K | 0.01% |
54,225
+18,735
| +53% | +$151K |
|
|
SPN
1112
DELISTED
Superior Energy Services, Inc.
SPN
| $468K | 0.01% |
2,773
+413
| +18% | +$68.9K |
|
1113
Jabil
JBL
$32.8B
| $464K | 0.01% |
19,615
+3,097
| +19% | +$67.5K |
|
|
CLCD
1114
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $463K | 0.01% |
+12,716
| New | +$450K |
|
|
SCMP
1115
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $461K | 0.01% |
34,044
+2,833
| +9% | +$39.5K |
|
|
PE
1116
DELISTED
PARSLEY ENERGY INC
PE
| $460K | 0.01% |
13,055
+1,953
| +18% | +$69.1K |
|
1117
Compass Minerals
CMP
$1.24B
| $459K | 0.01% |
5,858
+704
| +14% | +$53.5K |
|
1118
CVB Financial
CVBF
$3.98B
| $459K | 0.01% |
20,012
+6,985
| +54% | +$138K |
|
1119
Ralph Lauren
RL
$22.2B
| $458K | 0.01% |
5,075
-4,447
| -47% | -$452K |
|
1120
Zebra Technologies
ZBRA
$12.4B
| $458K | 0.01% |
5,342
+1,011
| +23% | +$74.9K |
|
|
JBTM
1121
JBT Marel
JBTM
$7.14B
| $458K | 0.01% |
5,328
+1,875
| +54% | +$153K |
|
|
RVNC
1122
DELISTED
Revance Therapeutics, Inc.
RVNC
| $458K | 0.01% |
22,124
+2,139
| +11% | +$35.8K |
|
|
PNRA
1123
DELISTED
Panera Bread Co
PNRA
| $458K | 0.01% |
2,231
+354
| +19% | +$71.7K |
|
|
BECN
1124
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $456K | 0.01% |
9,906
+3,661
| +59% | +$164K |
|
|
AXE
1125
DELISTED
Anixter International Inc
AXE
| $456K | 0.01% |
5,621
+1,883
| +50% | +$136K |
|
Similar funds
ProShare Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ProShare Advisors held 1,787 positions worth $9.03B, up 26% from $7.16B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2016, opening 329 new positions and adding to 1,367 existing holdings. Its largest new stake was Opko Health: 373,523 shares worth $3.47M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Linear Technology Corp, an estimated $2M trimmed.
- ProShare Advisors's largest Q4 2016 buy was Opko Health: 373,523 shares worth $3.47M.
- ProShare Advisors added most to Apple in Q4 2016, an estimated $58.9M increase.
- ProShare Advisors's biggest Q4 2016 reduction was Linear Technology Corp, cutting an estimated $2M.
- ProShare Advisors fully exited Post Properties in Q4 2016, selling an estimated $1.06M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.03B portfolio in Q4 2016.
- ProShare Advisors opened 329 new positions and closed 46 in Q4 2016.
- ProShare Advisors's portfolio value rose 26% quarter-over-quarter to $9.03B.
Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.